ClinicalTrials.gov
public full text
Public Domain
Peri-operative Aspirin Continuation Versus Discontinuation
This study evaluates the continuation (non-discontinuation) of Aspirin during TURBT. Half of participants will continue their usual low-dose Aspirin regimen during TURBT and throughout the perioperative period, while the other half will discontinue Aspirin use ten days prior to surgery (standard recommendation) and restart therapy two weeks post-discharge.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Recto Colonic Endoscopic Mucosal Resection and Polypectomy Under Clopidogrel#1339943
- Platelet activation, aspirin, and cancer: From basic science to clinical trials#327614
- The Effect of IV Cangrelor and Oral Ticagrelor Study#1212945
- OPTImal Management of Antithrombotic Agents: OPTIMA-5#1139653
- Endoscopic Mucosal Colonic Resection and Polypectomy Under Aspirin#1213079
Record · ID 1372076
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive